Insider Trading & Ownership of Kevin T. Conroy

Location: Madison, WI
Summary: The estimated net worth of Kevin T. Conroy is at least $18,214,806 dollars as of 22 May 2026. Kevin T. Conroy is the Director of ABBOTT LABORATORIES and owns shares of ABBOTT LABORATORIES (ABT) stock worth about $13.73M. Kevin T. Conroy is the President and CEO, Director of EXACT SCIENCES CORP and owns shares of EXACT SCIENCES CORP (EXAS) stock worth about $3.18M. Kevin T. Conroy is the Director of ALIGN TECHNOLOGY INC and owns shares of ALIGN TECHNOLOGY INC (ALGN) stock worth about $959K. Kevin T. Conroy is the Director of SomaLogic, Inc. and owns shares of SomaLogic, Inc. stock worth about $250K. Kevin T. Conroy is the Director of Adaptive Biotechnologies Corp and owns shares of Adaptive Biotechnologies Corp (ADPT) stock worth about $94.9K.
Signature: /s/ Julie Ann Coletti, Attorney-in-Fact for Kevin T. Conroy
All Insider Reports: All Insider Reports

Follow Filing Activity

Follow Kevin T. Conroy and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Key facts

Kevin T. Conroy has 7 issuer positions tracked on this page.
Estimated disclosed ownership value: $18,214,806.
Recent insider filing activity is available below.

Change

Largest disclosed position: ABBOTT LABORATORIES ($13,730,777).
Past-year value change for that position: .

Research use

This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
You can cross-check role, issuer, and filing chronology directly against the SEC source.